HealthReutersabout 3 hours ago
AstraZeneca partners with Oracle on AI trials
1 min read
On Oct 20, AstraZeneca announced a partnership with Oracle to utilize AI and real-world data for identifying eligible patients in clinical trials. The collaboration targets over $80 billion in annual revenue by 2030 and will initially focus on cancer, cardiovascular, respiratory, immunology and rare diseases, starting with hypertension research in Abu Dhabi.
Level
Hype check
Tap to vote and see what everyone thinks.
In this storyOracle
